SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bharat Kalra who started this subject6/14/2003 12:07:57 AM
From: Area51  Read Replies (2) of 1298
 
I think the CEGE science is enthralling (at one time this company was my largest holding), but I have a hard time evaluating it an investment vehicle. (For one thing I've never seen the potential market revenue estimated).

I'm also concerned about the annual summer to early fall market collapse, and I was thinking of possibly using CEGE as a source of funds because.
#1 - I gather they have a potential secondary offering in the works that could be a drag on the near term stock performance. (At least the annual report mentions a 180 million offering that they were preparing in February 2003 if I recall correctly)
#2 - It doesn't seem they have geared up any phase III stuff yet so it just looks like more safe and well tolerated phase II tests for the near term when it has already been shown to be safe and well tolerated?
#3 BIOM (Biomira) seems like a better cancer vaccine horse for the near term and Theratope results for breast cancer are likely to be revealed in the near term. Of course could be a worse horse if the results are unfavorable. Apparently a double blind study (even the medical staff doesn't know?) but some patients seem to improve markedly (at least if you believe the hype on yahoo <g>)
#4 - Some support likely at 9.75 - 10.25 so I may give it some room before cutting back my position.

Anyone aware of any near term catalysts for this stock (other than ABGX may appreciate or that investors may continue to became increasingly enthralled with bio-tech stocks)?)?

BIOM on a tear of late if anyone is interested:
siliconinvestor.com

Comments Appreciated,
Area51
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News